Health Policy Manag.
2021 Mar;31(1):1-4. 10.4332/KJHPA.2021.31.1.1.
Overlooking the Era of Vaccine against Coronavirus Disease 2019
- Affiliations
-
- 1Editor-in-Chief, Health Policy and Management
- 2Department of Preventive Medicine, School of Medicine, Ewha Womans University, Seoul, Korea
- KMID: 2514656
- DOI: http://doi.org/10.4332/KJHPA.2021.31.1.1
Abstract
- With this as a momentum of approval Pfizer vaccine against coronavirus disease 2019 (COVID-2019), it is changed to the era of vaccine rapidly. Most countries are trying to reserve effective vaccines and inoculate vaccines into high-risk populations for achieving community immunity. I reviewed several vaccine-related issues to be confronted for moving up to the end of COVID-2019: the efficacy and effectiveness of the approved vaccines, the priorities for vaccination into target groups, side effects, and distrust towards COVID-2019 vaccines. Evidence-based decision-making in the policy process and collaboration with professional groups are the most effective strategies for driving successful vaccination policy.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Coronavirus disease 2019 (COVID-19) vaccine platforms: how novel platforms can prepare us for future pandemics: a narrative review
- Steroid injections in pain management: influence on coronavirus disease 2019 vaccines
- Evidence-Developing Disease Control of Coronavirus Disease 2019
- Is the impact of childhood vaccines on coronavirus disease 2019, which is moderate in pediatric patients, possible?
- Current updates and research on plant-based vaccines for coronavirus disease 2019
